Comparing Eyelash Overgrowth from Cancer Treatments
Author Information
Author(s): Gershon Rotem, Vishnevskia-Dai Vicktoria, Amnie Asrat Genet
Primary Institution: Sheba Medical Center, Ramat-Gan, Israel
Hypothesis
How do Tyrosine kinase inhibitors (TKIs) and Prostaglandins (PGs) differ in causing megalotrichosis?
Conclusion
TKI-induced megalotrichosis occurs faster and may be more bothersome than PG-induced megalotrichosis.
Supporting Evidence
- TKIs-induced megalotrichosis had more individual elongated eyelashes.
- Patients treated with TKIs reported more complaints related to megalotrichosis.
- Time from drug introduction to megalotrichosis presentation was shorter with TKIs.
Takeaway
Some medicines can make your eyelashes grow longer. This study looked at two types of medicines to see which one makes eyelashes grow faster and how they look.
Methodology
The study analyzed medical data from 11 patients with megalotrichosis, comparing those treated with TKIs and PGs.
Potential Biases
Referral bias may have influenced the patient selection, as those with more severe symptoms were more likely to be referred.
Limitations
The small sample size and potential referral bias may limit the generalizability of the findings.
Participant Demographics
6 patients treated with PGs (median age 71) and 5 patients treated with TKIs (median age 60), with a mix of genders.
Statistical Information
P-Value
p = .047
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website